Target intelligence / Profile preview

ATP-Sensitive Potassium Channel on Pancreatic Beta Cell (KATP channel)

Target
KATP channel
Molecular classification
Ion channel, Potassium channel, ATP-gated channel, Hetero-octameric complex
01

Overview

The ATP-sensitive potassium channel (KATP channel) in pancreatic beta cells is a crucial molecular sensor that links cellular metabolism to electrical activity, thereby regulating insulin secretion. It plays a central role in glucose homeostasis by coupling changes in intracellular ATP/ADP ratios—reflecting metabolic status—to the membrane potential and subsequent insulin release. The KATP channel is a hetero-octameric complex composed of four pore-forming Kir6.2 subunits and four regulatory sulfonylurea receptor 1 (SUR1) subunits. At low glucose concentrations, KATP channels remain open, keeping the beta cell membrane hyperpolarized and suppressing insulin secretion. When blood glucose rises, increased metabolism elevates intracellular ATP levels. ATP binds to and inhibits KATP channels, causing them to close, leading to membrane depolarization, opening voltage-dependent calcium channels, and triggering exocytosis of insulin-containing granules. Sulfonylurea drugs bind SUR1 subunits and close the channel independently of ATP levels, stimulating insulin release. Mutations can cause neonatal diabetes (gain-of-function) or congenital hyperinsulinism (loss-of-function). Polymorphisms such as E23K in Kir6.2 are associated with an increased risk for late-onset type 2 diabetes.

Other names
Pancreatic Beta Cell KATP channelATP-sensitive K+ channelSulfonylurea receptor
02

Mechanism of action

Sulfonylureas bind to SUR1 subunits and close the channel independently of ATP levels, stimulating insulin release.

03

Biological functions

Regulation of insulin secretionCoupling metabolism to electrical activityGlucose homeostasisRegulation of membrane potential
04

Disease associations

Neonatal diabetes mellitusType 2 diabetes mellitusCongenital hyperinsulinism
05

Safety considerations

Hypoglycemia (with sulfonylureas)Potential for inappropriate insulin secretion
06

Interacting drugs

Sulfonylureas

Beyond the preview

Go deeper on ATP-Sensitive Potassium Channel on Pancreatic Beta Cell (KATP channel).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-Sensitive Potassium Channel on Pancreatic Beta Cell (KATP channel).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call